Skip to main content
. 2022 May 8;11(9):2648. doi: 10.3390/jcm11092648

Table 3.

Cox regression proportional hazard overall survival and recurrence-free survival: multivariable model for overall patients.

Recurrence-Free Survival Overall Survival
Variables Hazard Ratio (95%CI) p Hazard Ratio (95%CI) p
Propofol (ref. sevoflurane) 1.04 (0.80, 1.34) 0.80 1.12 (1.06, 1.17) 0.91
Age, year 1.02 (1.01, 1.03) 0.004 1.05 (1.03, 1.07) 0.000
ASA (ref. I) 0.025 0.61
II 1.11 (0.82, 1.50) 0.46 0.71 (0.41, 1.26) 0.24
III or IV 1.76 (1.14,2.73) 0.01 0.93 (0.42, 2.04) 0.85
Preoperative test
    Haemoglobin, mg/dL 1.00 (0.98, 1.01) 0.61 0.99 (0.95, 1.04) 0.68
    Albumin 0.83 (0.65, 1.07) 0.15 0.14 (0.72, 0.47) 0.14
    Creatinine, g/dL
Neutrophil/Lymphocyte ratio 1.07 (1.02, 1.11) 0.006 1.12 (1.06, 1.17) 0.000
Neoadjuvant therapy 1.70 (1.23, 2.34) 0.001
ECOG performance (ref. 0) 0.73 0.09
    1 0.91 (0.70, 1.18) 0.48 1.27 (0.80, 2.01) 0.31
    2 1.12 (0.51, 2.49) 0.78 1.29 (0.42, 4.00) 0.66
    3 2.30 (0.30, 17.86) 0.43 22.84 (1.80, 290.72) 0.02
Operation (ref. laparotomy) 0.005 0.009
    Laparoscopy 1.17 (0.72, 1.88) 0.53 0.51 (0.31, 0.84) 0.009
    Robotic 1.66 (1.22, 2.25) 0.001 0.15 (0.24, 0.89) 0.04
T staging (ref. T0 or T1) 0.000 0.000
    T2 1.24 (0.77, 2.00) 0.37 0.99 (0.38, 2.55) 0.98
    T3 2.88 (1.79, 4.65) 0.000 2.32 (0.90, 5.98) 0.08
    T4 88.36 (4.87, 14.35) 0.000 8.48 (2.95, 24.40) 0.000
Tumor location (ref. Right) 0.05
    Left 0.60 (0.39, 0.92) 0.019
    Rectum 1.51 (0.19, 11.92) 0.70
Lymphatic invasion 1.44 (1.12, 1.86) 0.005 1.62 (1.01, 2.60) 0.048
Perineural invasion 1.67 (1.27, 2.21) 0.000 1.42 (0.84, 2.37) 0.19
Vascular invasion 1.84 (1.38, 2.47) 0.000 0.40 (0.20, 0.55) 0.000
Anaesthesia time, min 1.00 (1.00, 1.00) 0.16 1.00 (1.00, 1.00) 0.18
Transfusion 0.93 (0.51, 1.71) 0.81 1.20 (0.50, 2.89) 0.69
Postoperative treatment 0.94 (0.67, 1.34) 0.74 0.68 (0.37, 1.25) 0.21

ASA, American Society of Anesthesiologists; BMI, body mass index; CAD, coronary artery disease; CCI, Charlson Comorbidity Index, CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; ECOG, Eastern Cooperative Oncology Group.